Sabinsa adds Canadian patent
This article was originally published in The Tan Sheet
Executive Summary
The Piscataway, N.J.-based dietary supplement manufacturer on Aug. 6 says it has added a patent from Canada to its U.S., European and Japanese patents protecting its Bioperine branded ingredient, which is derived from piperine black pepper extract, for use as a bioavailability enhancer. The firm says Bioperine is the only piperine that can legally be used in Canada to enhance the bioavailability of nutrients in supplement products. Sabinsa retained exclusive U.S. proprietary rights to its BioPerine and Forslean (coleus forkskohlii) ingredients in June with a final judgment by the U.S. District Court for the District of New Jersey against DNP International, which Sabinsa sued for patent infringement because it marketed and distributed piperine and coleus for uses previously researched and patented by Sabinsa in the late 1960s (1"The Tan Sheet" July 9, 2007, In Brief)...
You may also be interested in...
Sabinsa secures process patent
Sabinsa Corp. secures a new herbal manufacturing process patent covering its proprietary method of easily accessing known polyphenols and a streamlined approach to discovering unknown polyphenolic compounds, the company announces Aug. 27. The Piscataway, N.J.-based firm won the '324 patent six months after submitting materials to USPTO related to the methods and processes used to manufacture stilbene-polyphenols which exhibit various health benefits including resveratrol, oxyresveratrol and pterostilbene. The patent also covers the firm's process for synthesizing biologically active polyphenolic compounds by novel dalkylation, an aromatic poly o-demethlyation process used in polyphenol manufacturing. The firm recently added Canadian protection to its list of U.S. and international patents protecting its Bioperine brand ingredient 1("The Tan Sheet" Aug. 13, 2007, In Brief)...
District court upholds herbal extract patents
Herbal extract firm Sabinsa Corp. retains exclusive proprietary rights to BioPerine (piperine black pepper extract) and Forslean (coleus forkskohlii), the U.S. District Court for the District of New Jersey says in a June 27 final judgment against DNP International. The ruling upholds the validity and enforceability of the '382, '596 and '712 patents pertaining to Sabinsa's products. DNP agreed to discontinue importing, manufacturing and/or marketing piperine, coleus and coleus oil for sale in the United States. Sabinsa sued DNP for patent infringement because it marketed and distributed piperine and coleus for uses previously researched and patented by Sabinsa in the late 1960s, the company says. Piscataway, N.J.-based Sabinsa manufactures Phytonutrients and Ayurvedic herbal extracts for nutritional, pharmaceutical and food products...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”